A Phase 4 interventional study of gadoteric acid in Arterial Occlusive Disease, sponsored by Guerbet. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2008-11-26.
Sponsored by Guerbet · Phase 4 and Interventional
This is a clinical study of gadoteric acid in non-coronary MR angiography.
296 studies on the registry are indexed under Arterial Occlusive Diseases; 46 are open to participants now.
Browse Arterial Occlusive Diseases studies →Guerbet is the lead sponsor of 41 studies on the registry; 2 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 6 (86%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
This study is completed, as verified in Nov 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Guerbet